RAMSAY GENERALE DE SANTE SA (GDS.PA) Stock Fundamental Analysis
EPA:GDS - Euronext Paris - Matif - FR0000044471 - Common Stock - Currency: EUR
Taking everything into account, GDS scores 2 out of 10 in our fundamental rating. GDS was compared to 6 industry peers in the Health Care Providers & Services industry. GDS has a bad profitability rating. Also its financial health evaluation is rather negative. GDS does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
GDS had negative earnings in the past year.
In the past year GDS had a positive cash flow from operations.
Of the past 5 years GDS 4 years were profitable.
GDS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -0.83%, GDS is not doing good in the industry: 76.92% of the companies in the same industry are doing better.
GDS has a worse Return On Equity (-4.78%) than 76.92% of its industry peers.
GDS has a worse Return On Invested Capital (1.78%) than 73.08% of its industry peers.
GDS had an Average Return On Invested Capital over the past 3 years of 1.33%. This is below the industry average of 3.37%.
The last Return On Invested Capital (1.78%) for GDS is above the 3 year average (1.33%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.83% | ||
| ROE | -4.78% | ||
| ROIC | 1.78% |
ROA(3y)0.56%
ROA(5y)0.57%
ROE(3y)3.07%
ROE(5y)3.32%
ROIC(3y)1.33%
ROIC(5y)1.08%
1.3 Margins
Looking at the Operating Margin, with a value of 2.48%, GDS is doing worse than 69.23% of the companies in the same industry.
In the last couple of years the Operating Margin of GDS has declined.
GDS's Gross Margin of 78.75% is fine compared to the rest of the industry. GDS outperforms 76.92% of its industry peers.
GDS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.48% | ||
| PM (TTM) | N/A | ||
| GM | 78.75% |
OM growth 3Y24.12%
OM growth 5Y-11.7%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.38%
GM growth 5Y-0.57%
2. Health
2.1 Basic Checks
GDS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
GDS has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for GDS remains at a similar level compared to 5 years ago.
Compared to 1 year ago, GDS has an improved debt to assets ratio.
2.2 Solvency
GDS has an Altman-Z score of 1.01. This is a bad value and indicates that GDS is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.01, GDS is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
The Debt to FCF ratio of GDS is 8.96, which is on the high side as it means it would take GDS, 8.96 years of fcf income to pay off all of its debts.
GDS has a Debt to FCF ratio (8.96) which is comparable to the rest of the industry.
A Debt/Equity ratio of 3.23 is on the high side and indicates that GDS has dependencies on debt financing.
With a Debt to Equity ratio value of 3.23, GDS is not doing good in the industry: 73.08% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.23 | ||
| Debt/FCF | 8.96 | ||
| Altman-Z | 1.01 |
ROIC/WACC0.31
WACC5.64%
2.3 Liquidity
A Current Ratio of 0.81 indicates that GDS may have some problems paying its short term obligations.
GDS's Current ratio of 0.81 is on the low side compared to the rest of the industry. GDS is outperformed by 65.38% of its industry peers.
A Quick Ratio of 0.72 indicates that GDS may have some problems paying its short term obligations.
GDS has a Quick ratio (0.72) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.81 | ||
| Quick Ratio | 0.72 |
3. Growth
3.1 Past
GDS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -209.12%.
Looking at the last year, GDS shows a small growth in Revenue. The Revenue has grown by 6.49% in the last year.
The Revenue has been growing by 8.04% on average over the past years. This is quite good.
EPS 1Y (TTM)-209.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-144.12%
Revenue 1Y (TTM)6.49%
Revenue growth 3Y7.57%
Revenue growth 5Y8.04%
Sales Q2Q%5.78%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
GDS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GDS is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of GDS indicates a rather cheap valuation: GDS is cheaper than 88.46% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.78 | ||
| EV/EBITDA | 8.83 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
GDS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:GDS (6/16/2025, 7:00:00 PM)
11.1
-0.1 (-0.89%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners39.92%
Inst Owner ChangeN/A
Ins Owners6.59%
Ins Owner ChangeN/A
Market Cap1.23B
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.24 | ||
| P/FCF | 2.78 | ||
| P/OCF | 2.02 | ||
| P/B | 1.09 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.83 |
EPS(TTM)-0.49
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)3.99
FCFY35.91%
OCF(TTM)5.5
OCFY49.58%
SpS45.35
BVpS10.21
TBVpS-10.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.83% | ||
| ROE | -4.78% | ||
| ROCE | 2.44% | ||
| ROIC | 1.78% | ||
| ROICexc | 1.84% | ||
| ROICexgc | 3.43% | ||
| OM | 2.48% | ||
| PM (TTM) | N/A | ||
| GM | 78.75% | ||
| FCFM | 8.79% |
ROA(3y)0.56%
ROA(5y)0.57%
ROE(3y)3.07%
ROE(5y)3.32%
ROIC(3y)1.33%
ROIC(5y)1.08%
ROICexc(3y)1.41%
ROICexc(5y)1.17%
ROICexgc(3y)2.61%
ROICexgc(5y)2.14%
ROCE(3y)1.82%
ROCE(5y)1.48%
ROICexcg growth 3Y32.93%
ROICexcg growth 5Y-19.53%
ROICexc growth 3Y30.51%
ROICexc growth 5Y-13.14%
OM growth 3Y24.12%
OM growth 5Y-11.7%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.38%
GM growth 5Y-0.57%
F-Score4
Asset Turnover0.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.23 | ||
| Debt/FCF | 8.96 | ||
| Debt/EBITDA | 6.46 | ||
| Cap/Depr | 38.17% | ||
| Cap/Sales | 3.35% | ||
| Interest Coverage | 0.61 | ||
| Cash Conversion | 107.94% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.81 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | 1.01 |
F-Score4
WACC5.64%
ROIC/WACC0.31
Cap/Depr(3y)44.5%
Cap/Depr(5y)45.51%
Cap/Sales(3y)3.84%
Cap/Sales(5y)4.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-209.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-144.12%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.49%
Revenue growth 3Y7.57%
Revenue growth 5Y8.04%
Sales Q2Q%5.78%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.03%
EBIT growth 3Y33.51%
EBIT growth 5Y-4.6%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y79.01%
FCF growth 3Y-4.21%
FCF growth 5Y63.68%
OCF growth 1Y43.86%
OCF growth 3Y-3.47%
OCF growth 5Y22.4%